Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
21 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/21/3085602/0/en/GenVivo-Highlights-Non-Integrating-Retroviral-Vector-Technology-with-Persistent-Payload-Expression-at-the-2025-Retroviruses-Meeting.html
13 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/13/3079932/0/en/GenVivo-Highlights-GEN2-Phase-1-Data-and-GEN-1013-Preclinical-Data-at-the-2025-American-Society-of-Gene-Cell-Therapy-ASGCT-Annual-Meeting.html
26 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/26/3068699/0/en/GenVivo-Highlights-GEN-1013-A-Novel-Delivery-of-an-IL-12-Immunotherapy-at-the-2025-American-Association-for-Cancer-Research-AACR-Annual-Meeting.html
08 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/08/2977483/0/en/GenVivo-to-Present-Phase-1-Trial-Results-for-GEN2-A-Personalizing-Gene-Vector-Therapy-at-the-2024-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html
ABOUT THIS PAGE